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Abstract
Background: Despite the reduction in glycemic derangement in patients with type 1 diabetes mellitus (T1D)
through dietary and therapeutic adjustments implemented before, during and after continuous exercise, evidence
for its effectiveness with intermittent forms of exercise, such as soccer, is still lacking.
Methods/design: We designed a study protocol for a randomized, crossover, double-blinded, controlled trial,
for the evaluation of the effect that a strategy of dietary and therapeutic modifications may have on safety and
performance of persons with T1D in soccer training sessions and cognitive testing. Inclusion criteria comprise: age
older than 18 years, more than 2 years since T1D diagnosis, low C-peptide level, a stable insulin regimen, HbA1c
less than 9.0% and regular participation in soccer activities. Our primary outcome evaluates safety regarding
hypoglycemia events in patients using dietary and therapeutic adjustments, compared with the performance
under the implementation of current American Diabetes Association (ADA) usual recommendations for nutritional
and pharmacological adjustments for exercise. Additionally, we will evaluate as secondary outcomes: soccer
performance, indexed by performance in well-established soccer skill tests, cognitive functions (indexed by Stroop,
digital vigilance test (DVT), Corsi block-tapping task (CBP), and rapid visual information processing (RVIP) tests), and
glycemic control measured with a continuous glucose monitor (CGM).
Discussion: Dietary and insulin adjustments standardized under a 4-step method strategy have never been tested
in a clinical trial setting with intermittent forms of exercise, such as soccer. We hypothesize that through this
strategy we will observe better performance by persons with T1D in soccer and cognitive evaluations, and more
stable control of glycemic parameters before, during and after exercise execution, indexed by CGM measurements.
Trial registration: ISRCTN, ISRCTN17447843. Registered on 5 January 2017.
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Background
The importance of encouraging people with type 1
diabetes mellitus (T1D) to be physically active is well-
established when pursuing goals such as overcoming a
sedentary lifestyle, improving weight control, ameliorating
pre-existing cardiovascular disease, and improving quality
of life [1]. The American Diabetes Association (ADA) rec-
ommends that individuals diagnosed with T1D participate
in regular exercise in attempts to improve different health
outcomes such as weight loss and optimal glycemic
control. However, routine practice of this intervention is
significantly hampered by the risk of exercise-induced
hypoglycemia [2]. Additionally, it is frequently ob-
served that people with T1D, concerned about having
hypoglycemic events while exercising, tend to increase
their caloric intake excessively, eventually leading to
vexing glucose variability and further challenging the
execution of physical activity [3].
Prior evidence has focused on the effects of certain
therapeutic and dietary adjustments on patients’ per-
formance when they participate in sports that involve
continuous physical exercise [4]. However, recent publi-
cations demonstrate safety, evidenced by protection in
terms of rates of hypoglycemic events by reducing
degludec insulin dosage in subjects with T1D, even with
different exercise intensity and modality (indexed by
lactate threshold and potentiometers) [5].
Therefore, it is pertinent to study similar pharmacological
and dietary interventions but with intermittent exercise.
This exercise modality is more demanding on the body
than continuous physical activity of the same average
intensity [6], with a greater rise in body temperature
(0.3 °C) and an added elevated blood lactate concentra-
tion when compared at a given percentage of VO2 max
[7]. Concomitantly, sweat loss during intermittent exercise
can exceed sweat loss during continuous exercise [8],
thereby increasing the reliance on carbohydrate (CHO) as
a substrate during this type of physical activity [9].
In contrast to continuous exercise that only comprises
the workload intensity and the total duration, intermit-
tent exercise consists of five main components: peak
work load intensity, peak workload duration, recovery
load, recovery duration, and the mean load [4]. A clinical
trial comparing continuous with intermittent physical
activity in subjects with T1D showed that a lower
amount of exogenous carbohydrate is required to main-
tain euglycemia during intermittent compared with
continuous activity, and this finding was not related to
increased hepatic glucose output but to significantly
lower glucose disposal in intermittent compared with
continuous activity. Metabolically, this was paralleled by
increased levels of counter-regulatory hormones (mainly
growth hormone and catecholamines), and substantially
higher levels of lactate in intermittent activity [10].
A realistic recommendation is that exercisers with
diabetes mellitus should take in adequate carbohydrate,
along with sufficient (albeit likely reduced) insulin before,
during, and after prolonged moderate-intensity or high-
intensity workouts to maintain and restore muscle and
liver glycogen and blood glucose, especially during that
window of opportunity for glycogen repletion right after
the end of exercise (within 30 min to 2 h after) [11].
It is also important to note that the speed with which
insulin is absorbed and its onset of action may be in-
creased by both local heating and massage at or near the
application site. In addition to changes in insulin dosage
and CHO intake, exercise itself may be used to prevent
hypoglycemia. For instance, performing a brief (10 s)
maximal intensity sprint either before or after a moderate
intensity exercise session may protect against hypoglycemia
onset, at least in the short run [11].
The effect that the modifications on blood glucose
levels before, during, and after exercise have on the
performance of athletes in this type of sport has not
been accurately established, and evidence addressing this
hypothesis is scarce [1]. To our knowledge there is only
one study [8] in adolescents with T1D that found that
hypoglycemia, but not hyperglycemia, impaired both the
patients’ sports performance (tennis, basketball, or soc-
cer skills) and their cognitive function. However, this
trial had some important limitations including the fact
that the sport performance tests were of a relatively
short duration and did not demonstrate how blood
glucose levels affected mental and physical stamina [12].
Campbell et al. [2] developed a 4-step method that
succeeded in protecting participants with T1D from both
hypoglycemia and hyperglycemia throughout exercise
periods and the 24-h interval following exercise sessions
[2]. This method includes the following interventions:
(1) 75% reduction of pre-exercise rapid-acting insulin
dose (or 50% if intermittent exercise) given before a
meal containing 1 g carbohydrate · kg-1 60 min prior to
physical activity [13]; (2) post-exercise meal containing
1 g low-glycemic index (GI) carbohydrate · kg-1 60 min
after physical activity with 50% reduction on rapid-
acting insulin dose [14]; (3) consumption of a bedtime
snack containing 0.3 g carbohydrate · kg-1 also with a
low GI and omitting prandial insulin administration for
this meal [15]; and (4) 20% reduction of basal insulin
across the day when physical activity is performed [2].
In clinical trials, this 4-step method has demonstrated
that it is possible to optimize blood glucose level during
and after exercise by making mealtime adjustments to
both rapid-acting and basal insulin, and to pre-exercise
and post-exercise carbohydrate composition [2]. How-
ever, previous clinical trials have focused on evaluating pa-
tients’ performance in continuous forms of sports like
running or cycling, whereas evidence supporting this 4-step
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strategy in intermittent activities such as soccer, tennis, and
basketball, is still lacking.
Therefore, we designed a protocol for a randomized,
crossover, double-blinded, controlled trial to evaluate the
effect that this 4-step strategy for blood glucose control
will have on patients’ performance in a series of soccer
training sessions and cognitive assessments, compared
with usual care recommendations. Moreover, in this
study protocol, we introduce the evaluation of this 4-
step method in a more realistic “real world” scenario of
sports practice, with simulation exercises based on the
soccer gameplay field. We hypothesize that participants
using the 4-step method will yield a better performance
both in soccer-simulated sessions and in cognitive func-
tion evaluations when compared to the implementation
of the usual ADA recommendations. We also expect
fewer glycemic derangements and better glycemic con-
trol before, during, and after the performance of physical




The aim of this research is to assess the safety (evaluated
as rate of hypoglycemia) that this 4-step strategy has on
patients with T1D after completing a series of simulated
soccer tests. As exploratory analysis, we will compare
the performance of the skills required to achieve a good
score in the selected test. We will also aim to identify an
optimal pre-exercise blood glucose level associated with
a better performance in simulated soccer tests. Finally,
we will evaluate the effect of this 4-step strategy for
blood glucose level control in the cognitive performance
(indexed by neuropsychological evaluations testing
executive functions, attention, working memory, psycho-
motor speed, and visual-spatial short-term memory) in
patients diagnosed with T1D.
Trial design
This is a randomized, crossover, double-blinded (subject
and evaluator), controlled trial. Participants will be ran-
domized to the order of the interventions assigned (real
4-step method versus usual recommendations (sham 4-
step method)), leaving a washout period of 3 weeks for
repeating assessments after switching groups. We follow
the standard protocol items: recommendation for inter-
ventional trials (SPIRIT) guidelines to cover all sections
involved in this protocol (see Additional file 1).
Participants
Eligibility criteria for this trial will be focused on selecting
patients with T1D that have a stable insulin regimen and
glucose control and are engaged regularly in exercise and
physical activities, as this is the target population to whom
we would like to generalize the results obtained. Table 1
lists the inclusion and exclusion criteria for this trial.
Participants are required to be able to understand instruc-
tions for motor and cognitive evaluations and to provide
informed consent, in order to be enrolled.
Recruitment
Recruitment of participants will be based mainly on re-
ferral by endocrinologists, internal medicine physicians
or other professionals involved in the care of patients
with T1D. However, we are also seeking to recruit pa-
tients in collaboration with members of the Diabetes
and Endocrinology Medical Association in Costa Rica
(ANPEDEM) and through the monthly meetings of the
People with Diabetes National Foundation in Costa Rica
(Dia Vida Foundation) and social media advertisements.
Additionally, Institutional Review Board (IRB)-approved
flyers with the trial information will be situated near the
lobby of clinics and hospitals where patients with T1D
attend for monitoring.
The trial research assistant will contact candidates
through personal or telephone interview and will complete
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Participants older than 18 years
More than 2 years of established T1D
Stable insulin regimen in the past 6 months indexed by
less than 20% change in total insulin daily dose
HbA1c less than 9.0%
Weekly physical activity of 90 min or more
Participation in recreational or competitive soccer-related
activities, at least four times per month
Participants able to provide informed consent
Any treatment regimen different from continuous subcutaneous insulin infusion or
multiple daily insulin injections
Any use of medications (other than insulin) known to affect glycemic control including
oral or parenteral steroids (except for inhaled steroids), metformin, SGLT2 inhibitors, GLP.1
agonists, thiazolidinedione, sulfonylureas, DPP-4 inhibitors, or any other oral antidiabetic
therapy
Detectable C-peptide in serum
Cognitive impairment comprising any substantial decrease in alertness, language
reception, or attention that might interfere with understanding instructions for motor and
cognitive testing, not including hypoglycemia unawareness
Chronic kidney disease (glomerular filtration rate less than 90 mL · min-1)




T1D type 1 diabetes, SGLT-2 sodium glucose cotransporter 2, GLP1 glucagon like peptide 1, DPP-4 dipeptidyl peptidase 4
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a pre-screening evaluation (see Table 3) form assessing all
of the inclusion and exclusion criteria. Participants that ful-
fill the eligibility criteria will be defined as potential partici-
pants of the clinical trial, and will receive the informed
consent form by mail or email. Afterwards, a face-to-face
meeting will be scheduled and during this session (visit 1),
the principal investigator will explain the methodology and
the design of the study in detail. The subject will also be
asked to give their written informed consent during this
visit, after they have asked questions and/or expressed their
concerns.
Baseline assessments
Baseline assessments will be carried out by a physician
and will take place after consent has been obtained and
before randomization. During this visit (visit 1), a phys-
ician will complete an evaluation with clinical data about
the subject’s physical activity routine, chronic diabetes
mellitus control, history of hypoglycemia, and body mass
index (BMI) measurement. Additionally, the following
laboratory evaluations will be performed: fasting plasma
glucose, serum C-peptide level, HbA1c and urinary albu-
min excretion in a spot urine sample. Following all base-
line assessments the subject will be randomized to their
respective arm.
One week after randomization, a second visit (visit 2)
will take place during which a certified physical educa-
tion teacher and a soccer trainer will give the partici-
pants a theoretical and practical explanation of the
training session exercises that will be conducted in the
trial. During this visit, the participants will execute a
short version of the simulated soccer exercises to be-
come familiar with them. Additionally, participants will
receive an educational session with an endocrinologist
with all of the indications to complete the blood glucose
management through insulin and dietary adjustments.
Intervention
The intervention will consist of either following the re-
cently published ADA usual recommendations of care
[12–16] before, during and after exercise (sham 4-step
method), or the real 4-step method (a meal 60 min pre-
exercise, with 50% of insulin dose; a low GI meal 60 min
post-exercise, with 50% of insulin dose; a low GI snack
at bedtime before sleep, omitting the insulin dose; and
20% reduction in the basal insulin dose). On the day
after exercise, participants will return to their usual full
basal insulin dose. Moreover, the type of insulin used in
the clinical trial will not differ from that used by the
participants prior to enrolling in the study. The ADA
guidelines suggest that short-acting insulin is reduced
depending on the mean exercise intensity in both
exercise modes [16].
There will be specific evaluation of the intermittent
modality of exercise, given that the main objective that
guides this exercise protocol is not to demonstrate
differences in the response of subjects with T1D to di-
verse exercise modalities, such as continuous versus
intermittent exercise. On the contrary, the intervention
will evaluate the impact in terms of the safety and
performance of a protocol that sets forth insulin dosage
along with carbohydrate intake diet modifications, com-
pared with usual-care recommendations stated by guide-
lines for the standard of care. It is worth adding that
other trials have evaluated the response of subjects to
the 4-step method [2, 14, 15] in protocols that had
evaluated continuous physical activity.
Active intervention: real 4-step method
Participants will come to the laboratory at 7:00 a.m. and
we will first obtain a resting, fasted venous blood sample
(via venipuncture) for the laboratory evaluations previ-
ously listed. The iPro2 Professional continuous glucose
monitor (CGM) with Enlite sensor (Medtronic, MN,
USA) will be installed at that time. Participants will then
consume a standardized cereal-based breakfast meal
(sugar-coated corn flakes, peaches, and semi-skimmed
milk; 1.3 g carbohydrate · kg-1 body mass). At 1:00 p.m.
participants will consume a standardized pasta-based
lunch meal (pasta, tomato-based sauce, cheddar cheese,
olive oil; 1.3 g carbohydrate · kg-1 body mass). Between
the morning and evening visits, participants will record
their self-measured glucose control every 2 h.
At 5:00 p.m. participants will arrive for the evening train-
ing session. Before starting this session, they will self-
administer a 50% reduced pre-meal rapid-acting insulin
dose into the abdomen (the injection site will be at the
mid-point between the iliac crest and the navel). Immedi-
ately after receiving this insulin dose, participants will
consume a pre-exercise carbohydrate bolus (sugar-coated
corn flakes, peaches and semi-skimmed milk; 1.0 g carbo-
hydrate · kg-1 body mass). Following this bolus, participants
will remain rested for 60 min, at which point a finger stick
sample for glucose testing will be drawn immediately
before starting with the training sessions.
At 60 min post-exercise, participants will self-administer
a pre-meal rapid-acting insulin dose reduced by 50%, into
the abdominal site contralateral to the previously adminis-
tered pre-exercise rapid-acting insulin injection. After
receiving this insulin dose, participants will consume a
carbohydrate-based meal (basmati rice, tomato-based
sauce, turkey breast, and an isomaltulose orange flavored
drink (10% solution); 1.0 g carbohydrate · kg-1 body mass)
designed to elicit a low GI (GI = 37) response [2].
Following this meal the participants will be discharged
and will continue recording interstitial glucose values
with the CGM until the subsequent morning visits. At
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180 min following the post-exercise meal (240 min post-
exercise), participants will consume a low-GI bedtime
snack (low fat yogurt with honey tap; GI = 38), equiva-
lent to 0.4 g carbohydrate · kg-1 body mass, and will omit
rapid-acting insulin. In order to improve adherence, par-
ticipants will be contacted before the bedtime snack to
ensure compliance, and they will be encouraged to repli-
cate their sleeping patterns as much as possible prior to
the training sessions.
The basal insulin dose after exercise will be reduced by
20% of the pre-trial basal dose. Nevertheless, the timing
will be maintained throughout as per each participant’s
individual regimen. Twenty-four hours afterwards, partici-
pants will return to their usual full basal insulin dose.
At 8:00 a.m. on the morning following each training as-
sessment, participants will return to the laboratory. Here
we will obtain another fasting blood sample through
venipuncture and subsequently provide them with a
standardized breakfast meal (sugar-coated corn flakes,
peaches, semi skimmed milk; 1.0 g carbohydrate · kg-1
body mass). With this meal, they will self-administer their
full unchanged rapid-acting insulin dose.
Following the consumption of breakfast, the partici-
pants will be discharged from the laboratory and
instructed to maintain CGM for an additional 11 h (i.e.,
24 h from exercise cessation). Also during this time, they
will continue to monitor their diet using a food record
diary and weighing their foods. We will provide the
participants with a smartphone application for the
recording of this information (MyFitnessPal App).
Control intervention: usual recommendations
(sham 4-step method)
Recently, ADA published a position statement about
physical activity and diabetes [16]. This statement ex-
plained how the variable glycemic responses observed in
association with physical activity makes it very difficult
to provide uniform recommendations for both the man-
agement of food intake and the insulin dosing regimen.
Nonetheless, several instructions in this document are
intended to help prevent hypoglycemia. To prevent low
blood glucose level during prolonged (>30 min), pre-
dominantly aerobic exercise, additional carbohydrate in-
take and/or reductions in the insulin dose are typically
required [12–16]. In addition to the changes in insulin
regimen and carbohydrate intake, a brief (10 s) maximal
intensity sprint could be performed before or after the
exercise session, as suggested in the ADA guidelines, to
prevent exercise-induced hypoglycemia [12]. The pos-
ition statement also recommends adjusting daily basal
insulin dose with reduced prandial bolus insulin and
low-GI carbohydrate feeding following evening exercise
for those on multiple daily injections [12]. Finally, inclu-
sion of a bedtime snack, overnight glucose checks, or
alarms and automatic pump suspension may also be
warranted [16].
Patients allocated to the control group, or sham 4-step
Method, will receive current usual recommendations as
stated by the ADA [16], but following the scheme estab-
lished with the real 4-step method (see Table 2 for the
comparison for both interventions). Prior to exercise,
the CGM will be installed at 7:00 a.m., and they will
receive their meals in the same amount and frequency
as in the real 4-step method, consisting of a breakfast
at 8:00 a.m., lunch at 1:00 p.m. and pre-exercise meal
at 5:00 p.m. All of the three meals will have the same
caloric content as in the real intervention, and there
will be no insulin modification for the first two meals.
Assuming that they will be performing moderately
intense physical activity later in the day, for up to
60 minutes, this group will receive a rapid-acting insu-
lin dose that will be 75% of their usual dose concomi-
tantly with the 5:00 p.m. meal prior to the onset of
physical activity.
Table 2 Scheme comparison of interventions delivered in the real and sham 4-step methods
Time Real 4-step method Control (sham) 4-step method
8:00 a.m. Breakfast Standardized cereal-based breakfast Standardized cereal-based breakfast
Insulin dose Unchanged Unchanged
1:00 p.m. Lunch Standardized pasta-based lunch Standardized pasta-based lunch
Insulin dose Unchanged Unchanged
5:00 p.m. Pre-exercise meal 1 g · kg-1 CHO bolus 1 g · kg-1 CHO bolus
Insulin dose 50% reduction 75% reduction
7:00 p.m. Post-exercise meal Low-GI 1 g · kg-1 CHO bolus Medium-GI 1 g · kg-1 dinner
Insulin dose 50% reduction No reduction
10:00 p.m. Snack Low-GI 0.4 g · kg-1 CHO snack Medium-GI 0.4 g · kg-1 CHO snack
Insulin dose No insulin administered No insulin administered
Regular hour for basal insulin Insulin dose 20% reduction No reduction
CHO carbohydrates, GI glycemic index
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One hour after finishing the exercise session, the par-
ticipants will receive a carbohydrate-based meal with the
same caloric content as the meal apportioned in the real
interventional arm; however, we will not use low-GI
food for this bolus. Contrarily we will give the partici-
pants traditional rice, tomato sauce, turkey breast, and
water. With this meal we would be providing about
1.0 g of carbohydrate · kg-1 of body mass. We will not
modify the insulin dosage administered with this meal,
considering that the ADA guidelines do not suggest any
specific change around this issue.
Participants will then go home where they will con-
tinue registering interstitial CGM. About 180 min after
dinner (approximately 240 min after finishing the
exercise session), the participants will be contacted to
remind them to eat a snack before going to bed. How-
ever, this will differ from the real intervention in that
this will not be a low-GI snack (200 mL of unsweetened
orange juice and half a banana), and will be equivalent
to 0.4 g of carbohydrate · kg-1 of body mass. Additionally,
participants will not administer any insulin dose with
this snack.
Current ADA guidelines [16] have not yet established
any basal insulin dosage adjustment after intermittent
exercise, and it remains for the treating physician to de-
cide on a case-by-case basis. However, we have added a
modification of 20% of the insulin dose in the interven-
tional arm, based on results obtained from recent trials,
an effect seen even with the newer basal insulin such as
degludec. [5] Therefore, participants following the sham
4-step method will not receive the post-exercise modifi-
cation in insulin dosage. However, in order to maintain
blinding of the control group, we will provide the un-
changed insulin dosage for them to administer in their
own homes after the exercise session finishes, in pre-
loaded and concealed insulin syringes, whereby they will
not be able to ascertain the dose that has been served.
Moreover, and with the aim of increasing adherence, the
participants will be contacted through phone calls in
order to remind them about eating the before-bedtime
snack and to self-administer the insulin treatment
provided by the trial.
At 8:00 a.m. on the morning following each training
assessment, participants will return to the laboratory.
Here we will obtain another fasting blood sample from
them via venipuncture and subsequently provide them
with a standardized breakfast meal (sugar-coated corn
flakes, peaches, semi-skimmed milk). With this meal,
they will self-administer their full unchanged rapid-
acting insulin dose.
Outcomes
A physician will follow the participants’ blood glucose
levels un-blinded, a week before each assessment ses-
sion. This control will be based on an email report of
the daily blood glucose levels 7 days before the training
session.
During each of the assessments (visits 3 and 6; see
Table 3) a CGM will be installed at 7:00 a.m. and will be
maintained until 48 h after the training session ends.
During each of these visits the participants will perform
the soccer performance evaluation at 5:00 p.m. These
training sessions must be separated by 3 weeks, with the
idea of reducing a possible “learning effect” associated
with repeated workouts. In the 48 h following each
training session, participants will be required to measure
their blood glucose level eight times (i.e., 2 h after dinner,
before going to bed, at 12:00 a.m., at 3:00 a.m., just before
breakfast, 2 h after breakfast, just before lunch, 2 h after
lunch, and just before dinner). They will also be provided
with a form where they will be required to register the ap-
pearance and timing of symptoms of hypoglycemia. Blood
glucose level will be evaluated using the Accu-Chek® Nano
Glucometer (Roche Servicios SA, Costa Rica) 30 min
Table 3 Study visits summary table
Assessments and interventions Pre-screening Visit 1 Visit 2 Visits 3, 6 Visit 5 Visits 4, 7
Review of eligibility criteria X
Demographic data and clinical evaluation X
BMI measurement and laboratory evaluation X
Theoretical and practical explanation of training exercises X
4-Step method and usual care recommendations educational sessions X X
Training sessions with simulated soccer exercises (LIST-P, LSST, LSPT) X
Cognitive evaluations X X
Efficacy of blinding assessment X X
Revision of self-monitoring of blood glucose after exercise session X
Approximated time 30 min 60 min 90 min 120 min 90 min 60 min
BMI body mass index, LIST-P Loughborough Intermittent Shuttle Test Prescribed and Self-Paced, LSST Loughborough Soccer Shooting Test, LSPT Loughborough
Soccer Passing Test
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before each assessment session, after each one of the
workouts, and before both the basal and 24-h cogni-
tive tests.
After completing the first evaluation, participants will
change their interventional arm, and both groups will re-
ceive a second educational session (visit 5) from an
endocrinologist, who will explain the details of their new
dietary and pharmacological interventions. Also in this
visit, we will assess the efficacy of blinding by asking
participants in which interventional arm they think they
are allocated, and how confident they are about their
answer.
Furthermore, participants will be seen the day follow-
ing each assessment visit (visits 4 and 7) during which
cognitive testing and self-monitoring of blood glucose
will be repeated. In the last visit (visit 7) we will assess
the efficacy of blinding again by asking participants in
which interventional arm they think they were allocated,
and how confident they are about their answer.
All participants will be instructed to replicate and
record their diets (MyFitnessPal App®) and maintain
their current insulin regimen, without modifying the
dose, injection site, or time of injection for 24 h before
each experimental trial day (visits 3 and 6). Participants
will also be instructed to maintain similar grades of
physical activity during the trial, avoiding strenuous
exercise during the previous 48 h and 48 h following the
simulated soccer drills.
The assessment sessions will occur on two separate
days (separated by 3 weeks) and consist of both cogni-
tive and physical activity evaluations. During the physical
activity assessments participants’ heart rate (HR) will be
traced with a Garmin Vivofit 2 Bundle with HR monitor
(Garmin©, Kansas, USA).
Primary outcome
We will compare the percentage of participants with one
or more confirmed hypoglycemic episodes (≤60 mg · dL-1)
in the next 24 h following the assessment session. Other
safety-related end points include changes in the mean and
variability of 24-h plasma glucose based on CGM. Per-
centages of participants with hypoglycemic events will be
calculated as categorized by the ADA70 and will be ana-
lyzed during the day (daytime; 6:00 a.m. to 11:59 p.m.),
during the night (nocturnal; 12:00 midnight to 05:59 a.m.),
and any time of day or night (24 h).
Precisely, hypoglycemic categories will include the follow-
ing: (1) any hypoglycemia (events whether confirmed by
self-measurement or not and whether symptomatic or
asymptomatic); (2) documented symptomatic hypoglycemia
(symptomatic events with plasma glucose ≤60 mg · dL-1);
(3) asymptomatic hypoglycemia (events confirmed by
plasma glucose ≤60 mg · dL-1 but without symptoms); and
(4) severe hypoglycemia (events requiring assistance by
another person to administer carbohydrate, glucagon, or
other therapy). Confirmed or severe hypoglycemia will
include documented symptomatic or asymptomatic events
together with severe events.
Secondary outcomes
The secondary outcomes will be comparisons of physical
and technical performance in soccer training sessions be-
tween groups through the tests as subsequently described.
Loughborough Intermittent Shuttle Test – Prescribed and
Self-Paced (LIST-P)
A modified and validated LIST protocol will be used as
an equivalent to the intermittent physical activity that is
performed during a soccer match. The LIST-P [17]
requires participants to run back and forth between two
lines 20 m apart. Each block of exercises consists of ~11
repeated cycles of walking, running (at a speed equiva-
lent to 95% VO2 max), jogging (at a speed equivalent to
55%) and sprinting (defined as running to the maximum
effort according to maximum VO2 max). Further, each
cycle includes three repeated shuttles of walking, one
15-m sprint, three repeated shuttles of running and
three repeated shuttles of jogging (Fig. 1). Audio signals
will help to dictate the speeds at which participants will
complete each shuttle.
The LIST-P will be modified to complete 45 min of
the test. This reduction in test duration will be estab-
lished in order to adjust the time of all evaluations to
approximately 60 min. Consequently, this 1-h training
session will have some similarity with previous clinical
trials of continuous physical activity and T1D in terms
of exercise duration, with the possibility of comparing
the rate of hypoglycemic episodes and blood glucose
control in participants. Therefore, the first two blocks of
exercises (Blocks 1 and 2 in Fig. 1) will be performed at
a prescribed-pace while the third and fourth blocks will
be “self-paced” (Block 3 in Fig. 1).
Prescribed pace is established according to the
VO2max reported during initial evaluation of the sub-
ject, when he or she was included in the clinical trial.
On block 1 of LIST-P the prescribed pace includes
repetitions of running at 95% VO2 max and 55% VO2
max (Fig. 1), whereas self-paced running will be de-
fined and tailored specifically according to the sub-
ject’s preference. The auto-imposed pace will try to
simulate conditions experienced during real gameplay,
where subjects will run faster or slower depending on
their physical capacity.
Prior to the beginning of the self-paced section, one
of the investigators will ask participants to replicate
the intensity and pattern of exercises done during the
prescribed-pace period over the self-paced blocks of
exercises. Evaluators will give no other verbal
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instructions during the self-paced blocks. The evalua-
tors will record the duration of time spent on each
activity mode (e.g., walking, running, jogging) for the
self-paced cycle and for the total distance covered in
the 15-min block.
Participants will consume 5 mL · kg-1 of a sugar-
free sport drink (Powerade Zero ®, Coca-Cola Com-
pany) before starting exercise, and then 3 mL · kg-1
body mass of the same beverage every 15 min dur-
ing the LIST-P protocol. Additionally, investigators
will record body mass before and after each training
session. Immediately after finishing each of the
blocks from the LIST-P, participants will undergo
psychometric testing using the perceived exertion
scale (RPE) [18], the felt arousal scale (FAS) [19]
and the feeling scale (FS) [20].
The participants will complete three 15-min blocks of
the LIST-P punctuated by 4-min resting periods. After
having completed the last block of LIST-P, participants
will have 5 min of recovery time, and another finger-
based capillary glucose sample will be obtained. After
this the participants will complete the second round of
Loughborough Soccer Passing and Shooting Tests
(LSPT) as subsequently described.
Loughborough Soccer Passing Test
The LSPT has been validated previously in several popu-
lations [21] and it has been established to reflect the
physical exercise and game dexterity required to execute
soccer practice. For example, it evaluates and scores the
player’s capacity for executing short passes correctly
with their feet. Previous trials [21] that applied this test
have been able to differentiate professional players from
those still in training in minor leagues, thus evidencing
the yield obtained from the test that further allows us to
evaluate the subject’s performance in this protocol.
The LSPT requires the participants to start with the
ball (Pioneer Pro #5, CICADEX, San José, Costa Rica)
next to their feet, standing next to the central cone. One
evaluator will start timing the test using a hand-held
stopwatch (Casio Handheld Stopwatch Timer Model
HS-3 V-1R, Casio Computer Co., Ltd, Tokyo, Japan),
from the moment the ball is touched forward moving
out of the inner rectangle.
A second evaluator will be responsible for verbally
identifying the color of the next target (i.e., meaning the
zone towards where the patient needs to kick the ball).
The specific target will be verbally identified just before
the participant completed the previous pass. This will be
Fig. 1 Schematic representation of the Loughborough Intermittent Shuttle Test - Prescribed and Self-paced (LIST-P). Modified from Ali et al. [17]
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repeated until the subject kicks the ball towards the four
established zones, a total of 16 times. The same exam-
iner will be used for each role to eliminate inter-rater
variability. The order of passes will be determined by
one of four randomly generated trial orders, so that each
trial will consist of eight long (green and blue) and eight
short (red and black) passing combinations.
The participants will be informed that the passes can only
be executed from within the designated passing area, be-
tween the set of marked lines (see Fig. 2). They will also be
instructed that upon retrieval from a previous pass, the ball
must cross two of the inner marked lines before the next
pass can be attempted. Furthermore, the players will be
instructed that in order to attain the best performance in
the LSPT they will have to execute the test as quickly as
possible and make the fewest mistakes. The second evalu-
ator will stop the clock when the last pass makes contact
with the target area. The players will not know about the
timing scores nor will they have any sort of performance
feedback at any time during the data collection period.
The second examiner will also be responsible for
recording the penalty time points accrued during the
test. Thus, the examiner will stay in a position that all
four target areas can be viewed. Penalty times will be
appointed for the following errors:
(1)5 s for missing the bench completely or passing the
ball towards the wrong bench
(2)3 s for missing the target area
(3)3 s for handling the ball
(4)2 s for passing the ball outside of the designated area
(5)2 s if the ball touches any of the cones
(6)1 s for every second spent over the designated 43 s
needed to complete the test
(7)1 s will be subtracted from the total time if the ball
hits the 10-cm strip in the middle of the target
Two trials of LSPT will be performed in each of the
soccer training assessments, and the best score taken as
the performance score.
Loughborough Soccer Shooting Test (LSST)
The LSST is also a validated test [21] that allows us to
evaluate the capacity of a player (in this case our sub-
jects) to score a goal within a simulated soccer gameplay
scenario. This particular aspect of the test reproduces
real-life conditions of gameplay, thus yielding a more
real score of the subject’s performance.
Immediately following completion of the LSPT protocol,
the participants will be evaluated with another capillary
Fig. 2 Schematic representation of the Loughborough Soccer Passing Test (LSPT). Ali A et al. [21]
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finger glucose level. After that, the trainer will proceed
with the evaluation of the LSST (see Fig. 3).
For this test, the boundary lines will be measured and
marked on the floor using a 5-cm yellow tape. The “shoot-
ing zone” will be a square area (8.5 × 8.5 m), with the near-
est line marked at a distance of 16.5 m from the goal line.
Four tall traffic cones will be placed on each corner of the
shooting zone. A standard gymnasium bench will be
placed in the middle of the far side of the zone to act as a
rebound board. The full-sized goal, measuring 2.44 ×
7.32 m, will be split into various scoring zones marked
with a 5-cm tape (Fig. 3); this whole area will be drawn on
a piece of polyethylene sheeting measuring 7 × 9 m.
To enhance the reality of the test, a static, life-size
mannequin goalkeeper will be used. The figure will
measure 1.9 m tall and 1.22 m at its widest point at the
base and the arm span. The goalkeeper will be posi-
tioned 5.5 m in front of the goal line, and the side (right
or left) will be changed depending on the experimenter’s
instructions. The goalkeeper will be set on a base with
four wheels to allow for ease of movement across the
goal center during experimentation.
When completing the LSST protocol, the ball will be
initially be placed on the marked cross in the middle of
the shooting zone (Fig. 2). The starting position for the
participant will be facing away from the goal within
0.5 m distance of the ball. On the evaluator’s call, the
player will sprint to the appropriate cone, will touch the
top of it, and then will return to play a “rebound” pass
against the bench; the participant will turn and control
the ball if necessary, and then will shoot at the goal
while within the shooting area.
The player then will follow up his shot by sprinting
past the goalkeeper. Each trial will consist of 10 shots
with 1-min resting periods between each shot sequence.
There will be six trial orders that will be randomly se-
lected for each player. The goalkeeper mannequin will
be positioned to the opposite side of the “left/right” call.
To prevent players from attempting shots at an “un-
realistically slow” speed, a minimum value of 64 km · h-1
will be set for the shot to be valid for this test protocol.
The Gamma SpeedTrac X radar gun (Gamma Sports,
Pittsburgh, USA) equipment will be used to measure the
shot speed.
During match play, the optimal placement of a ball to
beat the opposing goalkeeper is at the top and bottom
corners of the goal and the points associated with each
scoring zone will reflect this (Fig. 2). Furthermore, a
Fig. 3 Schematic representation of the Loughborough Soccer Shooting Test (LSST). Ali A et al. [21]
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coach would normally encourage the players to shoot
across the goalkeeper towards the open space of the goal
[12]. To replicate this within the LSST, the players will
be told that they can only score points if the ball strikes
the open side of the goal, i.e., the half not covered by the
mannequin goalkeeper.
Both left and right feet will be used during the LSST.
The trial orders will be devised so that players have five
shots for each foot per trial. The final score will be the
mean of the total cumulative points accrued from all the
shots on target. Those shots that were attempted from
outside the shooting zone, took more than 8.5 seconds
to complete, and/or were struck at less than 64 km · h-1,
will be completely disregarded.
The assessments will have the same order for every
participant regardless of the interventional arm alloca-
tion and will be conducted as follows: (1) LSPT numbers
1; (2) LSST numbers 1; (3) LIST-P; (4) LSPT numbers 2;
and (5) LSST number 2 (Fig. 4).
Additionally, as exploratory outcomes we will also as-
sess cognitive functions, given that hypoglycemia has
long been thought to influence these functions in people
with diabetes mellitus. A field study of school-aged chil-
dren with T1D has shown that low blood glucose level
impairs patients’ sports performance and produces detri-
mental cognitive effects, as measured by math test per-
formance [8]. In this sense we set forth to evaluate, as a
secondary outcome, the effect of the 4-step method on
the cognitive performance of the subjects, related also to
the frequency of hypoglycemic events and to the per-
formance in soccer indexed by the tests described. We
hypothesize that besides showing an adequate safety pro-
file (same or reduced number of hypoglycemic events),
the 4-step method will also allow the subjects to achieve
a better performance both in soccer and in cognitive
testing (see Fig. 5 for a summary of the planned study
interventions and assessments).
1. Stroop test
The Stroop test is a commonly used
neuropsychological tool that measures selective
attention and mental processing speed among the
cognitive functions that could be affected by
attentional fatigue [22]. Campbell et al. utilized the
Stroop test in a clinical trial that evaluated
participants with T1D during physical activity in a
sports camp. The investigators found that reading
and color recognition ability were susceptible to
impairment as a result of hypoglycemia [12].
Commercially available Stroop Color and Word
Tests (WPS Publish, Alaska, USA) will be used to
assess cognitive processing in our participants.
Scores will be determined for reading ability, color
recognition, and interference; the latter will be used
as an index of the subject’s capacity to maintain
attention during the interference caused by the color
changes in the typed words [23].
Stroop testing will take place immediately following
each soccer training session and during the morning
evaluation at 8:00 a.m. on the next day. Each of
these tests will take 2 to 5 min (time limit of 45 s
per slide) for the participants to complete.
Participants will be asked to complete the test using
three slides: (1) read as many colored words as
possible in 45 s; (2) name as many colors of a group
of “X” letters as possible in 45 seconds; and (3)
name the color in which a word is printed (e.g.,
“blue”, “green”, or “red” ink) and not the word itself,
which is a name of a color (e.g., the word “red”
printed in blue ink instead of red ink). Naming the
color of the word during this “interference” takes
longer and is more prone to errors than when the
color of the ink matches the word that names the
color [16]. Reading, color naming, and interference
scores will be converted to T scores according to the
manual of Golden and Stroop for further analyses.
2. Digit vigilance test
The digit vigilance test (DVT) works as a measure of
sustained attention and psychomotor speed.
Participants will be asked to cross out a specific
target number (6) as quickly as possible, which
appears randomly within 59 rows of 35 single digits
on two pages. The examiner will observe the
subject's performance on the demonstration rows
and then on the first five rows of the test to
determine whether corrective feedback is required to
discourage an inefficient or poorly motivated
response style (e.g., going too fast and missing
numbers or going too slow and focusing attention
on each individual number). Total time and errors of
omission will be recorded. For the first (practice)
administration, all participants will be asked to
complete the standard format (target = 6) [24].
3. Corsi block-tapping task
The Corsi block-tapping task (CBT) is widely used for
the assessment of visual-spatial short-term memory,
both in clinical practice and in experimental research
settings. Basically, it is a span task and, as such, a
visual-spatial analog to the digit span, as an index of
Fig. 4 Schematic representation of the order of soccer assessments
according to the protocol. LIST-P Loughborough Intermittent Shuttle
Test Prescribed and Self-Paced, LSST Loughborough Soccer Shooting
Test, LSPT Loughborough Soccer Passing Test
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verbal short-term memory. The examiner taps a
sequence of blocks, which the participant must
repeat subsequently in the correct sequential order. By
increasing the length of the sequences, the capacity of
the visual-spatial short-term memory can be
measured [25].
The participant will be seated in front of the
examiner, who subsequently will tap the cubes
starting with a sequence of two blocks. Two trials
will be given per block sequence of the same length.
If at least one of these is repeated correctly, the next
two trials of a sequence of an increased length will
be administered. The cubes will be touched with the
index finger at a rate of approximately one cube per
second (with no pauses between the individual
cubes). The participant will have to tap the cube
sequences in the same order immediately after the
examiner finishes. The sequences will gradually
increase in length. The test will be terminated if the
participant fails to reproduce two sequences of equal
length. Only a completely, correctly repeated
sequence will be scored as correct; self-corrections
will be permitted.
4. Rapid visual information processing task
The rapid visual information processing task (RVIP)
is a serial detection task used to probe visual
sustained attention and working memory processes.
The design of the task consists of a stream of single
digits (Arabic numerals 1–9) presented at a rate of
100–110 per minute. Participants are required to
detect targets comprising a sequence of three
consecutive odd or three consecutive even numbers.
In a typical paradigm, targets are presented at a rate
of four per 30 s. The critical performance variables
include the number of correct responses (“hits”), the
reaction time for hits, and the number of errors of
commission (response in the absence of a target) [26].
This RVIP version will be programmed using e-
prime (Version 1.1. Psychology Software Tools, Inc.,
www.pstnet.com). White numbers between 0 and 9
(excluding 1) will appear in the center of a black
computer screen. Each number is presented for
600 ms without a time gap between two succeeding
numbers. The participant will have to detect three
target sequences (“2–4–6”, “3–5–7”, and “4–6–8”)
and respond to them (within 1800 ms after the onset
of the last number) by pressing the space bar on the
keyboard when the last number of a target sequence
appears. The three target sequences will be displayed
on the screen during the whole session in order to
help the participants remember.
Each block will be composed of 150 numbers that
appear in a pseudo-random and fixed order; four
target sequences will be included in 50 numbers.
There will be 72 target sequences that appear during
the 9-min test session. In order to prevent a sequence
effect, six different RVIP versions will be created by
varying these six blocks and then balancing them and
pseudo-randomly assigning them to the participants.
Hits (H), false alarms (FA) and reaction time (RT) will
be recorded by the computer. All RTs shorter than or
equal to 100 ms will be excluded from further
analyses.
In a second step, the sensitivity A, measuring a subject's
ability to distinguish targets and non-targets:
Fig. 5 SPIRIT flow diagram. (A summary of the planned study interventions and assessments)
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A ¼ 0:5 þ P Hð Þ − P FAð Þ þ P Hð Þ − P FAð Þð Þ2ð =4P Hð Þ 1 − P FAð Þð ÞÞ;ð½ð
the response criterion B, reflecting the individual's
response tendency:

B ¼ P Hð Þ 1 − P Hð Þð Þ − P FAð Þ 1 − P FAð Þð Þ½ =P Hð Þ
1 − P Hð Þð Þ þ P FAð Þ 1 − P FAð Þð Þ;
and the SD for the mean RT of each individual will be
calculated. Sensitivity A, the number of hits, the SD and
the mean RT will be evaluated from two perspectives:
the level (e.g., the mean value of A over 9 min) and the
time course (e.g., the mean value of A for the first
3 min, the second 3 min and the last 3 min). The num-
ber of FA and the response criterion B will be only eval-
uated from the perspective of level. The SD and the
mean RT will only be computed for the hits [27].
Sample size
We estimated a sample size of 24 participants per group,
yielding a total sample size of 48 participants. However,
because of the crossover design of this trial we will only
need a total of 24 participants, as each of them will par-
ticipate in both interventional arms. We used the follow-
ing parameters for the sample size calculation: an alpha
value of 0.05, power of 80%, two different intervention
groups with a crossover design, and a minimal clinically
important difference between the groups compared of
40% in the frequency of hypoglycemic events. Consider-
ing also a 15% dropout rate during the clinical trial, we
obtained a required sample size of 28 participants for
each group.
Randomization
We will use block-stratified randomization, with random
2 − 4 sized blocks and stratified by gender. A statistician
not related to the protocol will generate the
randomization list using a web-based method (http://
www.randomizer.org) that will randomize the order of
the interventions assigned. We will then have sequen-
tially numbered, sealed, opaque envelopes with the allo-
cations inside, in order to maintain allocation
concealment throughout the randomization process.
After the patient is consented and enrolled in the trial,
an un-blinded endocrinologist (also in charge of the edu-
cational sessions) will open the assigned envelope, allo-
cate the subject to the group presented and coordinate
with the pharmacy and nutritional department for the
preparation of the insulin and dietary modifications
needed with respect to the interventional arm assigned.
As mentioned before, the main objective that guides
this exercise protocol is not to demonstrate differences
in the response of subjects with T1D to different exer-
cise modalities, such as continuous versus intermittent
exercise. On the contrary, we want to evaluate the im-
pact, in terms of safety and performance, of a protocol
that sets forth insulin dosage along with carbohydrate
intake diet modifications, compared with usual-care
recommendations stated by guidelines for standard of
care. This being said, it is worth adding that other trials
[2, 10, 11] have evaluated the response of subjects to the
4-step method, so we would be increasing knowledge of
this particular intervention.
Blinding
In this trial, both participants and assessors will be
blinded. Likewise, the statistical team in charge of data
analysis will not know the real allocation of the partici-
pants and will handle data as “intervention A” and
“intervention B”. In order to assure adequate blinding of
the participants, we developed a sham 4-step method
control intervention whereby we will administer the
usual ADA recommendations masked in a 4-step
method scheme similar to the real intervention (see
Table 2). In this way, participants will feel that both are
experimental trials even though they will be receiving
different insulin and dietary regimens. Furthermore, all
the assessors in charge of applying the soccer and cogni-
tive evaluations will also be blinded until the end of the
trial. We will have an un-blinded group of physicians
that will be in charge of assigning patients to their allo-
cations, applying and explaining the therapeutic and
dietary modifications for each intervention, and moni-
toring glucose parameters and dietary or physical activity
related adverse effects during the trial. Finally, before
switching groups and at the end of the trial, we will as-
sess the efficacy of blinding using a questionnaire that
will be administered to the participants.
Data collection
We will assemble a folder for each participant containing
the data collection sheet that will include information ac-
quired at the first visit on demographic data, clinical his-
tory, basal laboratory results, and the simulated soccer
tests and cognitive function evaluation scores.
Blood glucose levels will be documented with gluc-
ometers. Given the simultaneous participation of several
participants with T1D in the training sessions, five of
these devices will be available for the research team in
case of an accident or malfunction of an individual sys-
tem. Glucometers Accu-Check Nano will be calibrated
using the Accu-Check Smartview Glucose Control Solu-
tion every time and immediately before delivering them
to each subject. Using this system, we will be able to
identify if the glucometer is giving a correct value within
a range previously established for the protocol. In the
given case that the result is not within the desired range,
then the device will no longer be used in the trial At the
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end of the 24-h follow up, the investigation team will
check the recording after the training sessions and
compare it with the finger stick results.
Statistical methods
In order to evaluate glucose control, we will also com-
pare the two groups, using either Student’s paired t test
or the Wilcoxon-Mann-Whitney test, in terms of CGM
parameters that include: 24-h mean glucose levels, SD of
24-h glucose levels, area under the curve for 24-h glu-
cose, mean amplitude of glycemic excursions, number of
episodes of hypoglycemia (<60 mg · dL-1), time in
hypoglycemia (<60 mg · dL-1) during a 24-h period, time
in hyperglycemia (>180 mg · dL-1) during a 24-h period,
and range of postprandial glucose increase. The range of
glucose increase (from pre-meal to post-prandial peak
levels) after breakfast, lunch, and dinner, will also be
compared between the interventional groups, using ei-
ther repeated measures analysis of variance (ANOVA) or
the Kruskal-Wallis test, depending on the normality of
the data distribution.
We will assess for data from the LIST-P, LSPT, and
LSST, and the Stroop, DVT, DBT, and RVIP test scores
obtained for each assessment session, for normality of
distribution using histogram analysis, the Shapiro-Wilk
test and the Kolmogorov-Smirnov test. We will use a
logarithmic transformation for the correction of non-
normal data and will subsequently test for the differ-
ences between groups using Student’s paired t test. In
order to assess if the order of the intervention modified
the performance of individual participants, we will calcu-
late the difference of the scores obtained between the
two types of interventions (real intervention minus sham
4-step method) and then we will define an intervention
indicator variable that will take the value of 1 if the
subject started with the real 4-step method, and 0 if the
subject started with the sham 4-step method. We will
then fit a linear regression model with the difference
calculated as the response variable and the intervention
indicator along with other relevant covariates (age,
gender, BMI) as the independent variables. Moreover we
will test for time effect over the performance of the
participants in a time-varying regression model.
Additionally, Pearson correlation coefficients will be
calculated between each of the scores and the pre-
exercise blood glucose level, searching for linear correl-
ation between blood glucose values and the LIST-P,
LSPT, LSST, and Stroop test scores.
In the event that the data do not follow the normal
distribution even after the log-transformation, we will
conduct non-parametric analyses using the Wilcoxon-
Mann-Whitney test and calculate Spearman correlation
coefficients for the comparison between the two groups
of the performance scores in soccer and cognitive
tests, and for the linear correlation analysis, respect-
ively. A p value <0.05 will be considered significant
for the comparison of the scores.
Additionally, we will conduct exploratory analyses by
modeling the performance scores in soccer evaluations
adjusted by age, years since T1D diagnosis, HbA1c level,
weekly physical activity hours and Stroop test scores
using linear multiple regression. A p value <0.10 will be
considered significant to introduce a variable into the
multivariate regression model. The number of
hypoglycemic events and the percentage of other adverse
effects listed previously will also be compared among
groups using Student’s t test and the Fisher exact test,
respectively. All of the statistical analysis will be done
using Stata software (StataCorp LP® 13.1).
Ethical considerations
The principal investigator and the research assistant for
the trial will be responsible for enrolling and contacting
participants and conducting the informed consent
process. All participants will be assigned an individual
code and any personal health information (PHI) that
may identify the participants will be protected, and only
the research team will have access to it. Any relevant
changes in the study protocol and/or the informed con-
sent will be submitted to the independent review board
either as protocol deviation report or as protocol
amendments. The protocol will be registered in
www.isrctn.com before starting with the trial.
Consent and permissions
Participants that fulfill the eligibility criteria will be de-
fined as potential participants of the clinical trial, and
will receive the informed consent through either email
or physical mail. Afterwards, an in-person meeting will
be scheduled and during this session, the principal inves-
tigator will explain the methodology and the design of
the study in detail. The subjects will also be asked to
give written informed consent during this visit, after ask-
ing questions and/or expressing their concerns.
Adverse event monitoring
An un-blinded group of physicians and physical trainers
will be in charge of monitoring glucose derangements
and physical injuries that may arise during the assess-
ments. We have prepared protocol-based treatment and
dietary interventions that follow guidelines established
for both the usual recommendations and the 4-step
method groups, which will be executed in the case of
hyperglycemic or hypoglycemic events. Also, we will
record any adverse events observed during the execution
of the trial and, if required, report them directly to our
Ethics Committee for further evaluation. Additionally,
our technical team will check and calibrate each of the
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glucometers and CGM devices before using them in any
of the protocol assessments.
Discussion
During clinical trials the 4-step method has been dem-
onstrated to optimize blood glucose levels during and
after exercise by making mealtime adjustments to both
rapid-acting and basal insulin and to pre-exercise and
post-exercise carbohydrate composition [2]. The first
step of this method protects individuals with T1D from
concomitant and early exercise-induced hypoglycemia
[6], the second step prevents a rapid rise in blood glu-
cose because of an overcorrection with food using a
low-GI carbohydrate meal [7], and the third and fourth
steps are intended to guard against late-onset exercise-
induced hypoglycemia after physical activity [2, 11].
Intermittent exercise, such as soccer, is more demand-
ing on the body than continuous exercise of the same
average intensity [21]. The 4-step method has never
been tested in a clinical trial setting for the evaluation of
intermittent forms of exercise, such as soccer.
We expect that this protocol will stimulate the devel-
opment and execution of clinical trials to evaluate diet-
ary and pharmacological interventions that will help
patients with T1D engage in physical activity, reduce the
risk of glycemic derangements while conducting exer-
cise, and at the same time obtain the best physical and
cognitive performance possible.
Trial status
(1)Date of first enrollment: 1/8/2017
(2)Target sample size: 28 patients
(3)Recruitment status: pending
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